Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Clinical Chemistry and Laboratory Medicine|December 16, 1998
Activated immune system in patients with Huntington's diseaseF Leblhuber, J Walli, K Jellinger, et al.
Oncogene|August 25, 2009
Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expressionS Kaulfuss, S von Hardenberg, S Schweyer, et al.
American Journal of Medical Genetics. Part A|January 19, 2006
Association of Jacobsen syndrome and bipolar affective disorder in a patient with a de novo 11q terminal deletionD Böhm, K Hoffmann, F Laccone, et al.
Cytogenetic and Genome Research|November 20, 2002
Identification and characterization of murine Brunol4, a new member of the elav/bruno familyM Meins, S Schlickum, C Wilhelm, et al.
Brain : a Journal of Neurology|October 1, 1996
Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3K Bürk, M Abele, M Fetter, et al.
Prenatal Diagnosis|March 1, 2006
Prenatal diagnosis of a large de novo terminal deletion of chromosome 11qD Boehm, F Laccone, P Burfeind, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 1999
Age related axonal neuropathy in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD)T Klockgether, L Schöls, M Abele, et al.
Brain Pathology (Zurich, Switzerland)|November 6, 1998
An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patientsT Schmidt, G B Landwehrmeyer, I Schmitt, et al.
Pageof 4